key: cord-0787253-qiiwehnv
authors: Rodríguez, A. Roux; Lorente, M. García; Clap, E. Benito; Martín, L. San Feliciano; Nava, A.M. Cubo; Plata, B.
title: VP21.13: Late diagnosis of a complex heart disease due to COVID‐19 pandemic: the key role of prenatal monitoring and ultrasound anomaly assessment
date: 2021-10-14
journal: Ultrasound Obstet Gynecol
DOI: 10.1002/uog.24343
sha: 871010d4642518132f591d61a62ad7175c0e54a1
doc_id: 787253
cord_uid: qiiwehnv

nan

We carried out an exhaustive review of the clinical history of the cases of AVB recently diagnosed in our centre. Results: In the last 6 years, 5 cases of complete AVB have been diagnosed in our centre. None of the cases presented associated structural heart disease. There was one case that ended in a legal interruption of pregnancy in the second trimester due to the presence of cardiomegaly associated with data of heart failure. Two of the five cases were treated during pregnancy (with corticosteroids, terbutaline, immunoglobulins, and ritodrine), without achieving elevation of the FHR. All patients were carriers of anti-Ro and anti-La antibodies. In three patients, the detection of AVB was the first sign that the mother was a carrier of an autoimmune disease. One patient moved her home to another location, and there, the pregnancy was ended electively at week 34 of gestation by Caesarean section. The other three cases ended the pregnancy in our centre. In one case, an elective Caesarean section was performed for obstetric reasons. The other two cases ended by eutocic delivery. In one of them, intrapartum control was performed with CTG and fetal capillary pH. In the second, a CTG was performed only of the atrial beat, obtaining a fully interpretable CTG.

Of the three newborns who were born in our centre, only one of them needed a pacemaker due to the presence of ventricular extrasystoles with bigeminism. In the case of delivery in another centre, a pacemaker was implanted in the newborn immediately after the birth. The children are now in good condition, being monitored on an outpatient basis in pediatric cardiology. Conclusions: Complete AVB is a rare pathology in which intrauterine treatment is usually not effective. Delivery can be vaginal, as long as the fetal well-being can be adequately controlled. Cases without structural heart disease have a better prognosis, although many of these children end up requiring a pacemaker implant.

Late diagnosis of a complex heart disease due to COVID-19 pandemic: the key role of prenatal monitoring and ultrasound anomaly assessment Congenitally corrected transposition of the great arteries (CCTGA) is a rare congenital anomaly involving 0.003/1000 live births and making up 0.05% of congenital cardiac malformations. In this condition, the morphologically left ventricle is connected to the morphologically right atrium through the mitral valve and to the pulmonary artery, while the morphologically right ventricle is connected through the tricuspid valve to the morphologically left atrium and the aorta. Early diagnosis in prenatal anomaly scan is essential to plan management in the best possible way for both mother and child. We present a case of a 35-week pregnant woman attending a high-risk pregnancy clinic appointment, with no prenatal monitoring having been performed until then due to the patient's own decision in the context of the COVID-19 pandemic. The first anomaly ultrasound carried out showed CCTGA associated with Ebstein's anomaly with no fetal heart rate disorders. Multidisciplinary prenatal counseling was performed and referral to a specialised hospital was decided to minimise the risk of complications at birth. Despite the recommendations, the mother decided to deliver the baby to our hospital. After birth the newborn was safely transferred to the referral hospital in the first hours of life.

Despite the pandemic situation, National Health Systems must promote and guarantee prenatal care for all pregnant women, ensuring safe environments where patients are not afraid to go to health centres for prenatal care, offering appropriate information to clarify any possible doubts and preventing false information that may create unnecessary alarm. Delays in the diagnosis of severe congenital heart disease can lead to complications that could be avoided with appropriate and early management. In the case of complex anomalies, which can be life-threatening, early diagnosis is even more important, as the parents may consider termination of pregnancy.

VP21.14 Prenatal diagnosis of congenital heart disease: contribution of screening ultrasound Objectives: Ultrasound is the gold standard screening test for congenital heart disease. The aim of our work was to study the sensitivity of screening ultrasound to recognise congenital heart disease. Methods: It was a descriptive retrospective study from January 2016 to December 2019, about 74 fetus and newborn with congenital heart disease diagnosed before or after birth in the department of gynecology ''B'' and the department of neonatology of Charles Nicole hospital. Results: The prevalence of congenital heart disease was 6.7 per thousand birth. 8% had family history of congenital heart disease. Diabetes millitus was the most common maternal disease. Gestational diabetes was the most common dysgravidia (27%). 57 patients had a screening ultrasound. The diagnosis was suspected in 30 cases, ie. a sensitivity of 53%. The four chamber view was performed in 84% of the cases. The three vessels view was performed in 60% of the cases. The ultrasound operators were mainly the residents (37%) and physicians of the department (26%). Ultrasound checks were performed in 31% of cases. Fetal echocardiography was performed for 30 mother and ventricular septal defect was the most common heart defect. A polymalformative syndrome was associated in 12% of cases, a chromosomal abnormality in 4% of cases and intra uterine growth restriction in 27% of cases. We had 68 live births, four fetal deaths and two pregnancy interruptions. The neonatal mortality rate was 26%. Conclusions: Screening for congenital heart disease remains difficult today. Improving the sensitivity of screening ultrasound requires an investment in training, time and cost. 

Coarctation of the aorta (CoA) has a birth prevalence of about 1 every 3500 newborn and significant right dominant heart (RDH) is considered a prenatal indirect sign of this condition. The aim of this study was to evaluate the echocardiographic parameters more correlate with neonatal finding of CoA in fetuses with RDH. Methods: Retrospective analysis of fetuses with RDH referred from 2011 to 2021 was carried out. The evaluated prenatal parameters are described in table 1. Postnatal echocardiographic evaluation was performed for all cases to diagnose CoA. Results: We included 41 RDH: among them we identify 10 (24%) CoA. See table 1 for results. Conclusions: RDH is a risk factor for postnatal CoA especially when diagnosed in the second trimester

Prenatal diagnosis and postnatal outcome of left brachiocephalic vein abnormalities: a systematic review G. Gaeta 1 , V. Fesslova 2 , S. Spinillo 1 , M. Pozzoni 1 , M. Candiani 1 , A. Farina 3